Total Liabilities

$1.22B

Quarterly · Period ending: Jun 30, 2026 · USD

LGND Total Liabilities

Latest reported$1.22Bperiod endingJun 30, 2026

LGND Quarterly Total Liabilities ($7.30M → $1.22B)

Quarterly total liabilities

High-resolution chart · PNG

LGND total liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Total Liabilities — Quarterly (USD)
Period ending	Total Liabilities (USD)
Jun 30, 2026	1,218,359,000
Mar 31, 2026	534,783,000
Dec 31, 2025	543,425,000
Sep 30, 2025	526,601,000
Jun 30, 2025	120,075,000
Mar 31, 2025	109,901,000
Dec 31, 2024	111,335,000
Sep 30, 2024	113,688,000
Jun 30, 2024	91,207,000
Mar 31, 2024	107,348,000
Dec 31, 2023	86,303,000
Sep 30, 2023	101,330,000
Jun 30, 2023	93,213,000
Mar 31, 2023	164,759,000
Dec 31, 2022	165,183,000
Sep 30, 2022	234,307,000
Jun 30, 2022	273,923,000
Mar 31, 2022	311,992,000
Dec 31, 2021	476,431,000
Sep 30, 2021	461,590,000
Jun 30, 2021	469,766,000
Mar 31, 2021	549,281,000
Dec 31, 2020	652,760,000
Sep 30, 2020	549,625,000
Jun 30, 2020	547,933,000
Mar 31, 2020	524,021,000
Dec 31, 2019	727,683,000
Sep 30, 2019	696,895,000
Jun 30, 2019	760,383,000
Mar 31, 2019	834,014,000
Dec 31, 2018	699,889,000
Sep 30, 2018	1,406,222,000
Jun 30, 2018	1,238,471,000
Mar 31, 2018	257,490,000
Dec 31, 2017	252,374,000
Sep 30, 2017	237,574,000
Jun 30, 2017	230,615,000
Mar 31, 2017	230,945,000
Dec 31, 2016	230,732,000
Sep 30, 2016	230,472,000
Jun 30, 2016	224,883,000
Mar 31, 2016	221,361,000
Dec 31, 2015	229,538,000
Sep 30, 2015	229,519,000
Jun 30, 2015	235,709,000
Mar 31, 2015	230,828,000
Dec 31, 2014	233,621,000
Sep 30, 2014	229,500,000
Jun 30, 2014	36,761,000
Mar 31, 2014	40,470,000
Dec 31, 2013	55,100,000
Sep 30, 2013	56,862,000
Jun 30, 2013	60,303,000
Mar 31, 2013	67,767,000
Dec 31, 2012	77,775,000
Sep 30, 2012	76,271,000
Jun 30, 2012	86,142,000
Mar 31, 2012	92,555,000
Dec 31, 2011	113,704,000
Sep 30, 2011	120,099,000
Jun 30, 2011	122,108,000
Mar 31, 2011	129,144,000
Dec 31, 2010	80,408,000
Sep 30, 2010	122,008,000
Jun 30, 2010	124,941,000
Mar 31, 2010	131,475,000
Dec 31, 2009	138,063,000
Sep 30, 2009	126,583,000
Jun 30, 2009	141,435,000
Mar 31, 2009	154,285,000
Dec 31, 2008	181,813,000
Sep 30, 2008	145,237,000
Jun 30, 2008	141,002,000
Mar 31, 2008	141,731,000
Dec 31, 2007	144,163,000
Sep 30, 2007	185,234,000
Jun 30, 2007	194,244,000
Mar 31, 2007	455,063,000
Dec 31, 2006	298,701,000
Sep 30, 2006	483,057,000
Jun 30, 2006	524,434,000
Mar 31, 2006	513,047,000
Dec 31, 2005	425,038,000
Sep 30, 2005	414,461,000
Jun 30, 2005	404,113,000
Mar 31, 2005	407,209,000
Dec 31, 2004	407,783,000
Sep 30, 2004	247,700,000
Jun 30, 2004	237,318,000
Mar 31, 2004	233,818,000
Dec 31, 2003	230,527,000
Sep 30, 2003	210,201,000
Jun 30, 2003	199,875,000
Mar 31, 2003	203,153,000
Dec 31, 2002	196,594,000
Sep 30, 2002	37,361,000
Jun 30, 2002	40,645,000
Mar 31, 2002	87,884,000
Dec 31, 2001	175,348,000
Sep 30, 2001	169,136,000